Bio Techne Corp Stock Buy Hold or Sell Recommendation
| TECH Stock | USD 75.38 0.51 0.68% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Bio Techne Corp is 'Strong Sell'. The recommendation algorithm takes into account all of Bio Techne's available fundamental, technical, and predictive indicators you will find on this site.
Check out Bio Techne Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Bio and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Bio Techne Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
Bio |
Execute Bio Techne Buy or Sell Advice
The Bio recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bio Techne Corp. Macroaxis does not own or have any residual interests in Bio Techne Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bio Techne's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Bio Techne Trading Alerts and Improvement Suggestions
| Over 99.0% of the company shares are owned by institutional investors | |
| On 22nd of November 2024 Bio Techne paid $ 0.08 per share dividend to its current shareholders |
Bio Techne Returns Distribution Density
The distribution of Bio Techne's historical returns is an attempt to chart the uncertainty of Bio Techne's future price movements. The chart of the probability distribution of Bio Techne daily returns describes the distribution of returns around its average expected value. We use Bio Techne Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bio Techne returns is essential to provide solid investment advice for Bio Techne.
| Mean Return | 0.06 | Value At Risk | -3.19 | Potential Upside | 4.15 | Standard Deviation | 2.36 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bio Techne historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bio Techne Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bio Techne or Life Sciences Tools & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bio Techne's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.06 | |
β | Beta against Dow Jones | -0.13 | |
σ | Overall volatility | 2.36 | |
Ir | Information ratio | -0.03 |
Bio Techne Volatility Alert
Bio Techne Corp currently demonstrates below-average downside deviation. It has Information Ratio of -0.03 and Jensen Alpha of 0.06. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bio Techne's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bio Techne's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Bio Techne Fundamentals Vs Peers
Comparing Bio Techne's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bio Techne's direct or indirect competition across all of the common fundamentals between Bio Techne and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bio Techne or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bio Techne's fundamental indicators could also be used in its relative valuation, which is a method of valuing Bio Techne by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bio Techne to competition |
| Fundamentals | Bio Techne | Peer Average |
| Return On Equity | 0.0729 | -0.31 |
| Return On Asset | 0.0555 | -0.14 |
| Profit Margin | 0.13 % | (1.27) % |
| Operating Margin | 0.18 % | (5.51) % |
| Current Valuation | 12.19 B | 16.62 B |
| Shares Outstanding | 158.89 M | 571.82 M |
| Shares Owned By Insiders | 1.03 % | 10.09 % |
| Shares Owned By Institutions | 99.41 % | 39.21 % |
| Number Of Shares Shorted | 3.53 M | 4.71 M |
| Price To Earning | 74.38 X | 28.72 X |
| Price To Book | 5.56 X | 9.51 X |
| Price To Sales | 10.22 X | 11.42 X |
| Revenue | 1.16 B | 9.43 B |
| Gross Profit | 770.22 M | 27.38 B |
| EBITDA | 310.37 M | 3.9 B |
| Net Income | 168.07 M | 570.98 M |
| Cash And Equivalents | 247.03 M | 2.7 B |
| Cash Per Share | 6.30 X | 5.01 X |
| Total Debt | 419.54 M | 5.32 B |
| Debt To Equity | 0.19 % | 48.70 % |
| Current Ratio | 3.44 X | 2.16 X |
| Book Value Per Share | 13.46 X | 1.93 K |
| Cash Flow From Operations | 298.98 M | 971.22 M |
| Short Ratio | 3.43 X | 4.00 X |
| Earnings Per Share | 0.95 X | 3.12 X |
| Price To Earnings To Growth | 2.75 X | 4.89 X |
| Target Price | 85.25 | |
| Number Of Employees | 3.1 K | 18.84 K |
| Beta | 1.28 | -0.15 |
| Market Capitalization | 11.98 B | 19.03 B |
| Total Asset | 2.7 B | 29.47 B |
| Retained Earnings | 1.33 B | 9.33 B |
| Working Capital | 458.04 M | 1.48 B |
Note: Acquisition by Kim Kelderman of 1492 shares of Bio Techne at 66.97 subject to Rule 16b-3 [view details]
Bio Techne Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bio . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bio Techne Buy or Sell Advice
When is the right time to buy or sell Bio Techne Corp? Buying financial instruments such as Bio Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bio Techne in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Construction Materials Thematic Idea Now
Construction Materials
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Construction Materials theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Construction Materials Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Bio Techne Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.